申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20140228321A1
公开(公告)日:2014-08-14
The present invention provides compounds of Formula (I): (I), as defined in the specification and compositions comprising any of such novel compounds. These compounds are endothelial lipase inhibitors which may be used as medicaments.
本发明提供了公式(I)的化合物:(I),如规范所定义的和包含任何这样的新化合物的组合物。这些化合物是内皮细胞脂肪酶抑制剂,可用作药物。